Survival analysis for adult glioma in England and Wales

Journal of the Formosan Medical Association

Volumn 104, Issue 5, 2005, Pages 341-348

  Tseng, Ming Yuan ^a   Tseng, Jen Ho ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Brain neoplasms; Epidemiology; Glioma; Retrospective studies; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; EPENDYMOMA; FEMALE; FOLLOW UP; GLIOMA; HEMISPHERE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SURVIVAL RATE; UNITED KINGDOM; AGE; BRAIN TUMOR; MIDDLE AGED; MORTALITY; REGISTER; SEX DIFFERENCE; SURVIVAL;

AGE FACTORS; BRAIN NEOPLASMS; ENGLAND; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; REGISTRIES; SEX FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; WALES;

EID: 24944538042     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Quinn M, Babb P, Brock A, et al: Cancer trends in England and Wales 1950-1999. Office for National Statistics, London, 2001.
2. Bahemuka M, Massey EW, Schoenberg BS: International mortality from primary nervous system neoplasms: distribution and trends. Int J Epidemiol 1988;7:33-8.
3. Davis FG, Freels S, Grutsch J, et al: Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 1988;88:1-10.
4. Mahaley MS Jr, Mettlin C, Natarajan N, et al: National survey of patterns of care for brain-tumor patients. J Neurosurg 1989;71: 826-36.
5. Daumas-Duport C, Scheithauer B, O'Fallon J, et al: Grading of astrocytomas. A simple and reproducible method. Cancer 1988; 62:2152-65.
6. Kim TS, Halliday AL, Hedley-Whyte ET, et al: Correlates of survival and the Daumas-Duport grading system for astrocytomas. J Neurosurg 1991;74:27-37.
7. Kernohan JW, Mabon RF, Svien HJ: A simplified classification of gliomas. Proc Staff Meetings Mayo Clinic 1949;24:71-4.
8. Burger PC, Vogel FS, Green SB, et al: Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985;56:1106-11.
9. Kleihues P, Burger PC, Scheithauer BW: WHO international histological classification of tumors. Histological typing of tumors of the central nervous system. Springer-Verlag; New York, USA, 1993.
10. Kleihues P, Cavenee WK: WHO classification of tumors. Pathology and genetics of tumors of nervous system. IARC, Lyon, France, 2000.
11. Coleman MP, Babb P, Damiecki P, et al: Cancer survival trends in England and Wales, 1971-1995: deprivation and NHS region. Office for National Statistics, London, 1999.
12. Roberts RO, Lynch CF, Jones MP, et al: Medulloblastoma: a population-based study of 532 cases. J Neuropathol Exp Neurol 1991;50:134-44.
13. Coleman MP, Babb P, Mayer D, et al: Cancer survival trends in England and Wales, 1971-1995: deprivation and NHS region (CDROM). Office for National Statistics, London, 1999.
14. Carstairs V, Morris R: Deprivation and mortality: an alternative to social class? Community Med 1989;11:210-9.
15. Prior P, Woodman CB, Collins S: International differences in survival from colon cancer: more effective care versus less complete cancer registration. Br J Surg 1998;85:101-4.
16. Schrijvers CT, Coebergh JW, van der Heijden LH, et al: Socioeconomic variation in cancer survival in the southeastern Netherlands, 1980-1989. Cancer 1995;75:2946-53.
17. Burger PC, Green SB: Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 1987;59:1617-25.
18. Chandler KL, Prados MD, Malec M, et al: Long-term survival in patients with glioblastoma multiforme: clinical study. Neurosurgery 1993;32:716-20.
19. Kallio M, Sankila R, Jaaskelainen J, et al: A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984. Cancer 1991;68:1394-400.
20. Shugg D, Allen BJ, Blizzard L, et al: Brain cancer incidence, mortality and case survival: observations from two Australian cancer registries. Int J Cancer 1994;59:765-70.
21. North CA, North RB, Epstein JA, et al: Low-grade cerebral astrocytomas. Cancer 1990;66:6-14.
22. Grant R, Liang BC, Page MA, et al: Age influences chemotherapy response in astrocytomas. Neurology 1995;45:929-33.
23. Simpson JR, Norton J, Scott C, et al: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 1993;26:239-44.
24. Goodwin JS, Samet JM, Hunt WC: Determinants of survival in older cancer patients. J Natl Cancer Inst 1996;88:1031-8.
25. Sandeman DR, Sandeman AP, Buxton P, et al. The management of patients with an intrinsic supratentorial brain tumour. Br J Neurosurg 1990;4:299-312.
26. Micheli A, Mariotto A, Giorgi Rossi A: The prognostic role of gender in survival of adult cancer patients. Eur J Cancer 1998; 34:2271-8.
27. Watanabe K, Tachibana O, Yonekawa Y, et al: Role of gemistocytes in astrocytoma progression. Lab Invest 1997;76: 277-84.
28. Shaw EG, Scheithauer BW, O'Fallon JR: Supratentorial gliomas: a comparative study by grade and histologic type. J Neurooncol 1997;31:273-8.